Jiang, Yinghua
Ji, Yang
Zhou, Iris Yuwen
Liu, Ning
Sun, Phillip Zhe
Ning, Mingming
Dumont, Aaron S.
Wang, Xiaoying
Article History
Received: 17 October 2022
Revised: 11 November 2022
Accepted: 14 November 2022
First Online: 29 November 2022
Declarations
:
: The authors declare no competing interests.
: The authors declare no competing interests. LT3001 was provided from the Lumosa Therapeutics Co. Ltd, Taiwan (licensed by the USA patent-US2016/0083423A1).
: All data generated or analyzed during this study are included in this published article (and its supplementary information files).